Hamster Challenge Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication January 26, 2021 08:30 ET | Source: Vaxart, Inc. Vaxart, Inc. South San Francisco, California, UNITED STATES New pre-clinical histology data show that Vaxart’s oral vaccine protected against lung inflammation in hamster models An article published in Nature Medicine reports data from a collaboration with Stanford University researchers on in vitro activity of Vaxart’s COVID-19 vaccine Data from Vaxart’s Phase I COVID-19 trial expected to be released next week S...

Published: Jan 26, 2021 New pre-clinical histology data show that Vaxart’s oral vaccine protected against lung inflammation in hamster models An article published in Nature Medicine reports data from a collaboration with Stanford University researchers on in vitro activity of Vaxart’s COVID-19 vaccine Data from Vaxart’s Phase I COVID-19 trial expected to be released next week SOUTH SAN FRANCISCO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Vaxart Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by inject...